by Clinical Neuropsychologist | Saturday, October 12, 2024 | Dementia
Abstract INTRODUCTION Identifying people at high risk of Alzheimer’s disease (AD) dementia allows for timely intervention, which, if successful, will result in preventing or delaying the onset of the disease. METHODS Utilizing data from the Chicago Health and...
by Clinical Neuropsychologist | Saturday, October 12, 2024 | Dementia
Abstract INTRODUCTION In the aging brain, cognitive abilities emerge from the coordination of complex pathways arising from a balance between protective lifestyle and environmental factors and accumulation of neuropathologies. METHODS As part of the Rush Memory and...
by Clinical Neuropsychologist | Saturday, October 12, 2024 | Dementia
Abstract INTRODUCTION Blood tests have the potential to improve the accuracy of Alzheimer’s disease (AD) clinical diagnosis, which will enable greater access to AD-specific treatments. This study compared leading commercial blood tests for amyloid pathology and...
by Clinical Neuropsychologist | Friday, October 11, 2024 | Dementia
Abstract INTRODUCTION Understanding the relationship between amyloid beta (Aβ) positron emission tomography (PET) and Aβ cerebrospinal fluid (CSF) biomarkers will define their potential utility in Aβ treatment. Few population-based or neuropathologic comparisons have...
by Clinical Neuropsychologist | Friday, October 11, 2024 | Dementia
Abstract INTRODUCTION Recent technological advances have increased the risk that de-identified brain images could be re-identified from face imagery. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a leading source of publicly available de-identified...
